SCHEMBL1084809

SCHEMBL1084809

Oc1ccccc1-c1nc(N2CCN(Cc3ccccc3)CC2)c2ccc(Cl)cc2n1

nearest known ligand 0.80

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.80
MAPT P10636 4/20 0.80
TSHR P16473 1/20 0.80
L3MBTL1 Q9Y468 1/20 0.80
KDM4E B2RXH2 2/20 0.58
HPGD P15428 2/20 0.58
GLA P06280 1/20 0.58
GAA P10253 1/20 0.58
LMNA P02545 2/20 0.57
ACHE P22303 1/20 0.57
SMAD3 P84022 1/20 0.57
MEN1 O00255 2/20 0.56
KMT2A Q03164 2/20 0.56
SMN1; SMN2 Q16637 1/20 0.55
HIF1A Q16665 1/20 0.55
TDP1 Q9NUW8 1/20 0.55
HTR3E A5X5Y0 2/20 0.51
HTR3B O95264 2/20 0.51
HTR2C P28335 2/20 0.51
HTR3A P46098 2/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1084342 0.96 ALDH1A1 (0.74) ALDH1A1MAPTTSHRL3MBTL1KDM4E
SCHEMBL1084292 0.93 MAPT (0.69) ALDH1A1MAPTTSHRL3MBTL1KDM4E
SCHEMBL1084449 0.92 ALDH1A1 (0.67) ALDH1A1MAPTTSHRL3MBTL1KDM4E
SCHEMBL1084557 0.92 ALDH1A1 (0.67) ALDH1A1MAPTTSHRL3MBTL1KDM4E
SCHEMBL1084610 0.90 ALDH1A1 (0.64) ALDH1A1MAPTTSHRL3MBTL1KDM4E
SCHEMBL1084556 0.89 ALDH1A1 (0.78) ALDH1A1MAPTTSHRL3MBTL1KDM4E
SCHEMBL14406060 0.88 ALDH1A1 (0.61) ALDH1A1MAPTTSHRL3MBTL1KDM4E
SCHEMBL1084167 0.87 ALDH1A1 (0.61) ALDH1A1MAPTTSHRL3MBTL1KDM4E
SCHEMBL1083997 0.86 MAPT (0.60) ALDH1A1MAPTTSHRL3MBTL1KDM4E
SCHEMBL1084758 0.85 ALDH1A1 (0.73) ALDH1A1MAPTTSHRL3MBTL1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8343980-B2 Quinazoles useful as modulators of ion channels VERTEX PHARMACEUTICALS INCORPORATED (US) 2013-01-01 US disclosed
US-8343980-B2 Quinazoles useful as modulators of ion channels VERTEX PHARMACEUTICALS INCORPORATED (US) 2013-01-01 US disclosed
US-8153642-B2 Quinazolines useful as modulators of ion channels VERTEX PHARMACEUTICALS INCORPORATED (US) 2012-04-10 US disclosed
US-8153642-B2 Quinazolines useful as modulators of ion channels VERTEX PHARMACEUTICALS INCORPORATED (US) 2012-04-10 US disclosed
US-7713983-B2 Quinazolines useful as modulators of ion channels VERTEX PHARMACEUTICALS INCORPORATED (US) 2010-05-11 US disclosed
US-7713983-B2 Quinazolines useful as modulators of ion channels VERTEX PHARMACEUTICALS INCORPORATED (US) 2010-05-11 US disclosed
US-7678802-B2 Quinazolines useful as modulators of ion channels VERTEX PHARMACEUTICALS INCORPORATED (US) 2010-03-16 US disclosed
US-7678802-B2 Quinazolines useful as modulators of ion channels VERTEX PHARMACEUTICALS INCORPORATED (US) 2010-03-16 US disclosed